Meniere’s Disease Drug Market Share, Industry Trends, Size, Revenue, Demand, Growth Analysis forecast by 2026

Market Analysis: Global Meniere's Disease Drug Market

Meniere's disease drug Market

Market Definition: Global Meniere's Disease Drug Market

Meniere’s disease is a disorder of inner-ear that typically affects one ear, inner ear is responsible for hearing and balance. This condition can cause vertigo, ringing in the ear (tinnitus), feeling of pressure in the ear, specific type of dizziness in which patient feel like spinning, hearing loss that comes and goes. This is a chronic condition and can lead to permanent hearing loss but treatments and lifestyle changes can help to control the symptoms.

According to the report of National Institute on Deafness and Other Communication Disorders of America, the prevalence of Meniere’s disease is high in America and around 615,000 Americans are suffering from Meniere’s disease and the number of patients increasing every year. Massachusetts Eye and Ear (An international center for treatment and research and a teaching hospital of Harvard Medical School) reported that approximately 60,000 new cases of Meniere’s disease are diagnosed annually.

Get More Insights About Global Meniere's Disease Drug Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-menieres-disease-drug-market

Market Drivers

High prevalence of Meniere’s disease is driving the market growth

Increasing awareness of this disorder is another important factor for the market growth

Rising investment in the research & development for the treatments for this disease is expected to drive the market growth

Government initiative to increase awareness is elevating the market growth


Market Restraints

Lack of any approved drug or treatment option is restricting the market growth

Low healthcare expenditure in developing regions also acts as a market restraint

High cost of treatment for this disease can also hamper the market growth


Segmentation: Global Meniere's Disease Drug Market

By Type

Classic

Vestibular

Bilateral


By Mechanism of Action

Anti-Histamines

Benzodiazepines

Antinausea

Diuretics

Antibiotics

Steroids

Others


By Drugs Type

Meclizine

Diazepam

Prochlorperazine

Hydrochlorothiazide

Gentamicin

Dexamethasone

Others


By Devices type

Hearing Aid

Meniett device


By Treatment Type

Medications

Therapy or Hearing Aids

Surgery


By Route of Administration

Oral

Intravenous

Intratympanic

Others


By Distribution Channel

Online Pharmacy

Direct Tenders

Retailers

Others


By End-Users

Hospitals

Homecare

Specialty Clinics

Others


By Geography

North America

U.S.

Canada

Mexico


Europe

Germany

Italy

U.K.

France

Spain

Netherlands

Belgium

Switzerland

Turkey

Russia

Rest of Europe


Asia-Pacific

Japan

China

India

South Korea

Australia

Singapore

Malaysia

Thailand

Indonesia

Philippines

Rest of Asia Pacific


South America

Brazil

Rest of South America


Middle East & Africa

South Africa

Rest of Middle East & Africa



Know more about this report https://www.databridgemarketresearch.com/reports/global-menieres-disease-drug-market

Key Developments in the Market

In June 2019, Otonomy Inc. is developing Otividex drug for the treatment of Meniere’s disease which is under Phase 3 clinical trial, in November 2017 Otonomy Inc announced that the AVERTS-2 trial, conducted in Europe, achieved its primary endpoint (p value = 0.029) and Otividex demonstrated clinically significant treatment benefit for patients

In May 2018, FDA approved IDE study for the treatment of Meniere’s disease and intractable vertigo. In this study simultaneously labyrinthectomy and cochlear implantation can be done in unilateral Meniere's disease which further assists in determining speech perception, localization and quality of life outcomes


Competitive Analysis:

Global Meniere’s disease drug market

Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-menieres-disease-drug-market

Key Market Players:

The key market players in the global Meniere’s disease drug market are Abbott, Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound Pharmaceutical, Jubilant Cadista, Auris Medical, Pfizer Inc, Sun Pharmaceutical Industries Ltd, Novartis AG, Abbott, Bayer AG, GlaxoSmithKline plc, Amneal Pharmaceuticals LLC., LUPIN, Sanofi, Solvay, XOMA and others.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-menieres-disease-drug-market

Browse Trending Related Reports @

· Hallucinations and Delusions Treatment Market

Hypogonadism Drug Market

Carcinoid Syndrome Drug Market

Pyelonephritis Treatment Market

Rosacea Treatment Market

About Data Bridge Market Research:

Data Bridge Market Research


Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

4.7 Star App Store Review!
Cpl.dev***uke
The Communities are great you rarely see anyone get in to an argument :)
king***ing
Love Love LOVE
Download

Select Collections